MedReleaf Corp.
$100,700,000.00
10,600,000.00 Common Shares at $9.50
Initial Public Offering - Closed - Wednesday, June 7, 2017
Company Description
MedReleaf is a Licensed Producer of cannabis-based pharmaceutical products based in Markham, Ontario.
| Address: |
200 Bay Street, Suite 3800 Toronto, Ontario, M5J 2Z4 Canada |
|---|---|
| Phone Number: | 289 317 1004 |
| Fax Number: | |
| Website: |
| Industry: | Pharmaceuticals |
|---|---|
| Closing Date: | Wednesday, June 7, 2017 |
| 1st Day of Trading: | Wednesday, June 7, 2017 |
| Primary Symbol: | LEAF |
| Exchange: | Toronto |
Proceeds
The net proceeds of the offering will be used for the Bradford Facility build-out, for the expansion of existing manufacturing capacity, for clinical research and product development and for working capital and general corporate purposes.
| Gross Proceeds: | $100,700,000.00 |
|---|---|
| Underwrting Fees: | $5,892,000.00 |
| Expense Offering: | $2,000,000.00 |
| Net Proceeds: | $92,808,000.00 |
| Lead Underwriter: | GMP Securities Ltd. |
|---|---|
| Other Underwriter(s): |
Canaccord Genuity Corp. PI Financial Corp. Eight Capital |
Performance
| 1 day | 1 week | 1 month | 6 months | Inception | |
|---|---|---|---|---|---|
| Recent Performance | 0.00 % | 0.00 % | 0.00 % | 0.00 % | -97.63 % |
| Post IPO Performance | -22.84 % |
The content of this page is transmitted strictly for informational purposes. Investments must be selected in accordance with the investor's respective objectives. Desjardins Online Brokerage does not issue any recommendations or endorsements concerning any particular product, its potential value or appropriateness, or any specific strategy. It is highly recommended to read the prospectus before making any type of investment.